ENH PHARMA LTDActive

Company number 09149095Private limited companyIncorporated 2014

Key figures

£3,588,001-6.9%
Net assets 2024/25
+4.8%
Average annual growth 2021/22–2024/25
01 m2 m3 m4 m2021/222022/232024/25

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
02.5 m5 m7.5 m2021/222022/232024/25
Filed accounts2021/22–2024/25
2021/222022/232024/25
Turnover22,158,52522,306,00025,670,000
Cash at bank and in hand1,624,3342,066,0002,046,001
Total assets5,497,8896,010,0006,479,001
Total liabilities2,229,1722,158,0002,891,000
Net assets / total equity3,268,7173,852,0003,588,001
Average number of employees323543

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

The company's principal activity during the year was that of Outpatient Pharmacy Activity. The company was incorporated on 28 July 2014 in the United Kingdom. The registration number is 09149095 (England and Wales)

As described in the company's latest filed accounts.

Summary: ENH PHARMA LTD

Company

ENH PHARMA LTD is a private limited company registered with Companies House under company number 09149095. It was incorporated on 28 Jul 2014. Its status is active. The registered office is in Stevenage (SG1). Its nature of business (SIC 2007) is hospital activities (86101).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files full accounts. Turnover was £25,670,000. Net assets were £3,588,001, down 6.9% on the previous year. Cash at bank and in hand was £2,046,001. Total assets were £6,479,001 and total liabilities £2,891,000. The company had an average of 43 employees. Figures are available for 3 financial years (2021/22–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 18 Jun 2027.